ImmunityBio Inc IBRX インサイダー取引

ImmunityBio Inc (IBRX) インサイダー取引

フィルター:

日付	保有者名	取引株数	金額レンジ ($)	取引種別	価格レンジ ($)	届出終了時の株数	% 変化
2026-03-31	California Capital Equity, LLC法人	4.61M	25.00M	Derivative Exercise and Retained Stock	5.43	259.00M	1.81%
2026-02-24	Dr. Barry J. SimonChief Corporate Affairs Officer & Director	-75.00k	900.79k	Automatic Disposition	12.01	2.85M	-2.56%
2026-02-23	Ms. Christobel E. SeleckyIndependent Director	-25.00k	175.50k	Derivative Exercise and Sale	2.98 - 10.00	0.00	-
2026-02-22	Ms. Regan J. LauerCAO	2.39k	0.00	Derivative Exercise and Retained Stock	-	115.88k	2.11%
2026-02-22	Ms. Regan J. LauerCAO	-1.67k	14.56k	Derivative Exercise and Sale	8.70	115.88k	-
2026-02-22	Mr. Richard Gerald AdcockPresident, CEO & Director	74.88k	0.00	Derivative Exercise and Retained Stock	-	560.34k	15.42%
2026-02-22	Mr. Richard Gerald AdcockPresident, CEO & Director	-77.56k	674.77k	Derivative Exercise and Sale	8.70	560.34k	-
2026-02-22	Mr. David C. SachsCFO	19.97k	0.00	Derivative Exercise and Retained Stock	-	300.14k	7.13%
2026-02-22	Mr. David C. SachsCFO	-20.68k	179.93k	Derivative Exercise and Sale	8.70	300.14k	-
2026-02-22	Dr. Patrick Soon-ShiongFounder, Executive Chairman and Global Chief Scientific & Medical Officer	56.16k	0.00	Derivative Exercise and Retained Stock	-	291.46M	0.02%
2026-02-22	Dr. Patrick Soon-ShiongFounder, Executive Chairman and Global Chief Scientific & Medical Officer	-58.17k	506.08k	Derivative Exercise and Sale	8.70	291.46M	-
2026-02-22	Dr. Barry J. SimonChief Corporate Affairs Officer & Director	-15.24k	146.89k	Derivative Exercise and Sale	8.70 - 10.25	2.93M	-
2026-02-20	Dr. Barry J. SimonChief Corporate Affairs Officer & Director	-165.78k	1.69M	Automatic Disposition	9.25 - 10.25	2.93M	-5.36%
2026-02-10	Dr. Patrick Soon-ShiongFounder, Executive Chairman and Global Chief Scientific & Medical Officer	155.56k	0.00	Derivative Exercise and Retained Stock	-	291.41M	0.05%
2026-02-10	Dr. Patrick Soon-ShiongFounder, Executive Chairman and Global Chief Scientific & Medical Officer	-118.56k	821.62k	Derivative Exercise and Sale	6.93	291.41M	-
2026-02-10	Mr. David C. SachsCFO	39.59k	0.00	Derivative Exercise and Retained Stock	-	280.18k	16.46%
2026-02-10	Mr. David C. SachsCFO	-42.64k	295.52k	Derivative Exercise and Sale	6.93	280.18k	-
2026-02-10	Ms. Regan J. LauerCAO	3.23k	0.00	Derivative Exercise and Retained Stock	-	113.48k	2.92%
2026-02-10	Ms. Regan J. LauerCAO	-2.26k	15.64k	Derivative Exercise and Sale	6.93	113.48k	-
2026-02-10	Mr. Richard Gerald AdcockPresident, CEO & Director	134.07k	0.00	Derivative Exercise and Retained Stock	-	485.47k	38.16%
2026-02-10	Mr. Richard Gerald AdcockPresident, CEO & Director	-140.05k	970.53k	Derivative Exercise and Sale	6.93	485.47k	-
2026-01-20	Dr. Barry J. SimonChief Corporate Affairs Officer & Director	-151.97k	1.09M	Automatic Disposition	6.54 - 7.88	3.09M	-4.69%
2026-01-16	Ms. Christobel E. SeleckyIndependent Director	-75.00k	214.15k	Derivative Exercise and Sale	2.98 - 7.51	0.00	-
2025-12-31	Mr. David C. SachsCFO	14.96k	0.00	Derivative Exercise and Retained Stock	-	240.58k	6.63%
2025-12-31	Mr. David C. SachsCFO	-15.44k	30.56k	Derivative Exercise and Sale	1.98	240.58k	-
2025-12-31	Mr. Richard Gerald AdcockPresident, CEO & Director	16.97k	0.00	Derivative Exercise and Retained Stock	-	351.39k	5.08%
2025-12-31	Mr. Richard Gerald AdcockPresident, CEO & Director	-17.51k	34.67k	Derivative Exercise and Sale	1.98	351.39k	-